Search Results - Andrew Kent
- Showing 1 - 2 results of 2
-
1
Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single‐Center Retrospective Analysis Autoría: Jason S. Gilbert, Megan Connor, Grace Bosma, Jingjing Zhang, Christine M. McMahon, Maria L. Amaya, Jonathan Gutman, Marc Schwartz, Andrew Kent, Diana Abbott, Daniel A. Pollyea
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia Autoría: Michael K. Jones, Jesse Sanchez, Megan Connor, Katherine Julian, Rebecca Rezac, Kelsey Marciano, Jennifer Tobin, Grace Bosma, Diana Abbott, Katelyn Anttila, Connor Sohalski, Ayele Belachew, Christine McMahon, Andrew Kent, Maria Amaya, Mathew G. Angelos, Marc Schwartz, Jonathan A. Gutman, Daniel A. Pollyea
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso